Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.32 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 9/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12001731 | 0.90 | MAP3K14 (0.34) | MAP3K14CNR2 | |
| SCHEMBL12001801 | 0.90 | MAP3K14 (0.33) | MAP3K14RORCCNR2 | |
| SCHEMBL12001646 | 0.88 | MAP3K14 (0.37) | MAP3K14CNR2 | |
| SCHEMBL11970643 | 0.87 | MAP3K14 (0.47) | MAP3K14 | |
| SCHEMBL12001528 | 0.82 | MAP3K14 (0.31) | MAP3K14 | |
| SCHEMBL11970812 | 0.77 | MAP3K14 (0.48) | MAP3K14 | |
| SCHEMBL11970731 | 0.77 | MAP3K14 (0.46) | MAP3K14 | |
| SCHEMBL12001711 | 0.76 | MAP3K14 (0.34) | MAP3K14 | |
| SCHEMBL12001472 | 0.75 | TTBK1 (0.36) | MAP3K14 | |
| SCHEMBL12001492 | 0.74 | TTBK1 (0.35) | MAP3K14PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120214762-A1 | 6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR | GENENTECH, INC. (US) | 2012-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120214762-A1 | 6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR | NFKB1, NFRKB, NFKBIA | MAP3K14 519/4885PDK2 213/4885MAP4K1 622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.